Multi-year collaborations with global pharma.
Selected partner engagements span target discovery, indication expansion, repurposing, and clinical development. Specific outcome figures are illustrative; actual milestones are governed by individual partnership agreements.
Kyowa Kirin
2018–presentMulti-year strategic collaborationEnterprise-wide platform access. Multiple expansions of scope across therapeutic areas and modalities; first research-collaboration milestone achieved.
Shionogi
2021–presentMulti-target drug discoveryJoint identification, evaluation, and optimization of novel targets; Shionogi advances selected programs into research and clinical development.
Ono Pharmaceutical
2024–presentTarget identification across diseases of interestOno leverages AlphaMeld and ChatAlphaMeld to identify, evaluate, and optimize novel targets, with exclusive global commercialization rights to advancing candidates.
GSK Consumer Healthcare
2020–presentInnovation monitoring across consumer healthThree-year strategic collaboration applying AlphaMeld to capture consumer-specific innovation across GSK's key focus areas.
Sosei Heptares
2021–presentGPCR-focused target discoveryCombined AlphaMeld with Sosei Heptares' GPCR structure-based drug design to surface and validate undrugged GPCR targets in immunomodulation.
TB Alliance
2020–presentDrug-resistant tuberculosisApplication of AlphaMeld to identify and accelerate transformative therapies for the management, treatment, and cure of tuberculosis.
Nektar Therapeutics
CollaborationCytokine engineering & immuno-oncologyStrategic engagement with Nektar's R&D leadership informing AlphaMeld's translational approach to biologics innovation.
Centrexion
CollaborationNon-opioid painApplication of AlphaMeld in the pain therapeutic space, supporting target landscape work and program prioritization.
BioXcel Therapeutics
SpinoutSister-company spinoutValidated AlphaMeld outputs across BioXcel programs, including BXCL501 — among the first AI-platform-derived candidates to complete a successful Phase III readout.